|
|
|
|
| LEADER |
00000cam a2200000 i 4500 |
| 001 |
lb648885 |
| 003 |
CoU-L |
| 008 |
160420s2016 iluk b 001 0 eng |
| 005 |
20231002205547.1 |
| 010 |
|
|
|a 2016018814
|
| 020 |
|
|
|a 9781634254588
|q (physical book)
|
| 020 |
|
|
|a 1634254589
|q (physical book)
|
| 035 |
|
|
|a (OCoLC)947104740
|
| 035 |
|
|
|a .b6488857
|b lst1
|c -
|
| 040 |
|
|
|a DLC
|b eng
|e rda
|c DLC
|d OCLCO
|d CLU
|d OCLCF
|d UtOrBLW
|
| 042 |
|
|
|a pcc
|
| 043 |
|
|
|a n-us---
|
| 049 |
|
|
|a UCXA
|
| 082 |
0 |
0 |
|a 346.7304/86
|2 23
|
| 090 |
|
|
|a KF3133.B56
|b A753 2016
|
| 245 |
0 |
0 |
|a ANDA litigation :
|b strategies and tactics for pharmaceutical patent litigators /
|c Kenneth L. Dorsney, editor-in-chief.
|
| 246 |
3 |
|
|a Abbreviated New Drug Application litigation :
|b strategies and tactics for pharmaceutical patent litigators.
|
| 250 |
|
|
|a Second edition.
|
| 264 |
|
1 |
|a Chicago, Illinois :
|b ABA, American Bar Association, Section of Intellectual Property Law,
|c [2016]
|
| 300 |
|
|
|a xxvii, 957 pages :
|b forms ;
|c 26 cm
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent.
|
| 337 |
|
|
|a unmediated
|b n
|2 rdamedia.
|
| 338 |
|
|
|a volume
|b nc
|2 rdacarrier.
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
0 |
|t The statutory and regulatory scheme /
|r James M. Lennon,
|r Guy Donatiello --
|t The drug approval process : an overview /
|r Karen E. Keller --
|t Notice and prefiling considerations /
|r Rudolf E. Hutz,
|r Jeffery B. Bove,
|r Mary W. Bourke --
|t The litigation timeline /
|r Richard L. Horwitz,
|r Philip A. Rovner,
|r David E. Moore,
|r Jonathan A. Choa,
|r Alan R. Silverstein,
|r Bindu A. Palapura,
|r Stephanie E. O'Byrne --
|t Initiating litigation /
|r John L. Abramic,
|r Katherine H. Johnson,
|r Kevin A. O'Connor,
|r Aaron F. Barkoff --
|t Use of reissue proceedings in Hatch-Waxman litigation /
|r Andrew A. Alul,
|r Joseph M. Bennett-Paris,
|r Richard T. Ruzich --
|t Inter partes review in ANDA litigation /
|r Aaron Gleaton Clay,
|r Mark J. Feldstein,
|r William B. Raich --
|t Examining subject-matter jurisdiction over declaratory judgment claims filed in combination with patent infringement claims under Section 271(e)(2)(A) /
|r Stephen R. Auten,
|r Jane S. Berman --
|t Responding to the complaint /
|r Mark J. Feldstein,
|r Jonathan R. Davies,
|r Yoonhee Kim --
|t Discovery /
|r Gerard M. O'Rourke --
|t Experts /
|r Alejandro Menchaca,
|r Michael B. Harlin --
|t Claim construction /
|r Mark J. Feldstein,
|r Krista E. Bianco --
|t Summary judgment /
|r Gregory S. Gewirtz,
|r Arnold I. Rady,
|r Daniel P. Laine --
|t Remedies /
|r Kenneth L. Dorsney,
|r Gurpreet Singh Walia,
|r David S. Bloch,
|r Thomas J. Vetter --
|t Settlement /
|r Michael V. O'Shaughnessy,
|r Rebecca Harker Duttry --
|t Antitrust /
|r Asim M. Bhansali,
|r Benedict Y. Hur,
|r Sharif E. Jacob --
|t Pretrial preparation /
|r Jack B. Blumenfeld,
|r Karen Jacobs,
|r Jeremy A. Tigan --
|t Trial /
|r Rudolf E. Hutz,
|r Jeffrey B. Bove,
|r Mary W. Bourke,
|r Kristen Healey Cramer --
|t Posttrial /
|r Frederick L. Cottrell III,
|r Steven J. Fineman,
|r Jason J. Rawnsley,
|r Arun J. Mohan --
|t Appeals to the Court of Appeals for the Federal Circuit /
|r Michael J. Schaengold,
|r Scott A. Chambers,
|r Patrick J. McCarthy --
|t Hatch-Waxman practice in the Supreme Court of the United States /
|r David S. Block,
|r Steffen N. Johnson --
|t Managing an ANDA litigation /
|r Daniel E. Yonan,
|r Jonathan M. Strang,
|r Jonathon E. Boljesic --
|t Pharmaceutical regulation and litigation in foreign countries /
|r Kelly McClellan,
|r John Norman,
|r Grant Fisher,
|r Benjamin Hopper,
|r Gustavo de Freitas Morais,
|r Rodrigo Augusto Oliveira Rocci,
|r Caio Ribeiro Bueno Brandão,
|r Marie Manley,
|r Marina Vickers,
|r Ayako Kobayashi,
|r Hiroshi Nemoto,
|r Satoshi Ogawa.
|
| 650 |
|
0 |
|a Biotechnology
|z United States
|v Patents.
|0 http://id.loc.gov/authorities/subjects/sh2009117118
|
| 650 |
|
0 |
|a Patent laws and legislation
|z United States.
|0 http://id.loc.gov/authorities/subjects/sh2008108954
|
| 650 |
|
0 |
|a Drugs
|x Law and legislation
|z United States.
|0 http://id.loc.gov/authorities/subjects/sh2008102437
|
| 650 |
|
0 |
|a Pharmacy
|x Law and legislation
|z United States.
|0 http://id.loc.gov/authorities/subjects/sh2008109175
|
| 650 |
|
0 |
|a Pharmaceutical industry
|z United States.
|0 http://id.loc.gov/authorities/subjects/sh2008108871
|
| 650 |
|
0 |
|a Patent suits
|z United States.
|0 http://id.loc.gov/authorities/subjects/sh2008108955
|
| 650 |
|
0 |
|a Pharmaceutical industry.
|0 http://id.loc.gov/authorities/subjects/sh85039713
|
| 650 |
|
7 |
|a Biotechnology.
|2 fast
|0 (OCoLC)fst00832729.
|
| 650 |
|
7 |
|a Drugs
|x Law and legislation.
|2 fast
|0 (OCoLC)fst00898830.
|
| 650 |
|
7 |
|a Patent laws and legislation.
|2 fast
|0 (OCoLC)fst01054823.
|
| 650 |
|
7 |
|a Patent suits.
|2 fast
|0 (OCoLC)fst01054860.
|
| 650 |
|
7 |
|a Pharmaceutical industry.
|2 fast
|0 (OCoLC)fst01060129.
|
| 650 |
|
7 |
|a Pharmacy
|x Law and legislation.
|2 fast
|0 (OCoLC)fst01060303.
|
| 651 |
|
7 |
|a United States.
|2 fast
|0 (OCoLC)fst01204155.
|
| 655 |
|
7 |
|a Patents.
|2 fast
|0 (OCoLC)fst01423842.
|
| 700 |
1 |
|
|a Dorsney, Kenneth L.,
|e editor.
|0 http://id.loc.gov/authorities/names/n2012029978
|1 http://isni.org/isni/0000000371073453
|
| 710 |
2 |
|
|a American Bar Association.
|b Section of Intellectual Property Law,
|e sponsoring body.
|0 http://id.loc.gov/authorities/names/nr94002903
|1 http://isni.org/isni/0000000106982664
|
| 902 |
|
|
|a 220722
|
| 944 |
|
|
|a MARS - RDA ENRICHED
|
| 945 |
|
|
|l lst1
|
| 994 |
|
|
|a lst1
|
| 999 |
f |
f |
|i 8f1e15f8-89e5-531e-bfac-2b04aaf5d84f
|s 1f522c0f-8f81-5448-9d68-8d22be534082
|
| 999 |
|
|
|b 1
|c 160629
|d m
|e a
|f -
|g 0
|
| 952 |
f |
f |
|p Cannot circulate
|a University of Colorado Boulder
|b Law Campus
|c Law
|d Law Library - Stacks 1st floor
|e KF3133.B56 A753 2016
|h Library of Congress classification
|i journal
|m U182004859786
|n 1
|
